Brendan J. O'Brien - Publications

Affiliations: 
Australian National University, Acton, Australian Capital Territory, Australia 
Area:
visual system, retina, ganglion cells, voltage gated sodium channels

106 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Hadjinicolaou AE, Savage CO, Apollo NV, Garrett DJ, Cloherty SL, Ibbotson MR, O'Brien BJ. Optimizing the electrical stimulation of retinal ganglion cells. Ieee Transactions On Neural Systems and Rehabilitation Engineering : a Publication of the Ieee Engineering in Medicine and Biology Society. 23: 169-78. PMID 25343761 DOI: 10.1109/TNSRE.2014.2361900  1
2014 Nivison-Smith L, Acosta ML, Misra S, O'Brien BJ, Kalloniatis M. Vinpocetine regulates cation channel permeability of inner retinal neurons in the ischaemic retina. Neurochemistry International. 66: 1-14. PMID 24412512 DOI: 10.1016/j.neuint.2014.01.003  1
2013 Maturana MI, Wong R, Cloherty SL, Ibbotson MR, Hadjinicolaou AE, Grayden DB, Burkitt AN, Meffin H, O'Brien BJ, Kameneva T. Retinal ganglion cells electrophysiology: the effect of cell morphology on impulse waveform. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2013: 2583-6. PMID 24110255 DOI: 10.1109/EMBC.2013.6610068  1
2012 Cloherty SL, Wong RC, Hadjinicolaou AE, Meffin H, Ibbotson MR, O'Brien BJ. Epiretinal electrical stimulation and the inner limiting membrane in rat retina. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2012: 2989-92. PMID 23366553 DOI: 10.1109/EMBC.2012.6346592  1
2012 Wong RC, Cloherty SL, Ibbotson MR, O'Brien BJ. Intrinsic physiological properties of rat retinal ganglion cells with a comparative analysis. Journal of Neurophysiology. 108: 2008-23. PMID 22786958 DOI: 10.1152/jn.01091.2011  1
2012 Hadjinicolaou AE, Leung RT, Garrett DJ, Ganesan K, Fox K, Nayagam DA, Shivdasani MN, Meffin H, Ibbotson MR, Prawer S, O'Brien BJ. Electrical stimulation of retinal ganglion cells with diamond and the development of an all diamond retinal prosthesis. Biomaterials. 33: 5812-20. PMID 22613134 DOI: 10.1016/j.biomaterials.2012.04.063  1
2010 O'Brien BJ, Hirano AA, Buttermore ED, Bhat MA, Peles E. Localization of the paranodal protein Caspr in the mammalian retina. Molecular Vision. 16: 1854-63. PMID 21031018  1
2009 Isayama T, O'Brien BJ, Ugalde I, Muller JF, Frenz A, Aurora V, Tsiaras W, Berson DM. Morphology of retinal ganglion cells in the ferret (Mustela putorius furo). The Journal of Comparative Neurology. 517: 459-80. PMID 19790267 DOI: 10.1002/cne.22145  0.32
2008 O'Brien BJ, Caldwell JH, Ehring GR, Bumsted O'Brien KM, Luo S, Levinson SR. Tetrodotoxin-resistant voltage-gated sodium channels Na(v)1.8 and Na(v)1.9 are expressed in the retina. The Journal of Comparative Neurology. 508: 940-51. PMID 18399542 DOI: 10.1002/cne.21701  1
2007 Lynd LD, Goeree R, Crowther MA, O'Brien BJ. A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique. 14: e215-26. PMID 17652767  0.44
2006 Zupancic JA, Richardson DK, O'Brien BJ, Cronin CG, Schmidt B, Roberts R, Weinstein MC. Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infants. Early Human Development. 82: 97-103. PMID 16469456 DOI: 10.1016/j.earlhumdev.2006.01.004  0.44
2005 Lynd LD, Goeree R, O'Brien BJ. Antiviral agents for influenza: a comparison of cost-effectiveness data. Pharmacoeconomics. 23: 1083-106. PMID 16277546 DOI: 10.2165/00019053-200523110-00003  0.44
2005 Grootendorst PV, Marshall JK, Holbrook AM, Dolovich LR, O'Brien BJ, Levy AR. The impact of reference pricing of nonsteroidal anti-inflammatory agents on the use and costs of analgesic drugs. Health Services Research. 40: 1297-317. PMID 16174135 DOI: 10.1111/j.1475-6773.2005.00420.x  0.44
2005 Reed SD, Anstrom KJ, Bakhai A, Briggs AH, Califf RM, Cohen DJ, Drummond MF, Glick HA, Gnanasakthy A, Hlatky MA, O'Brien BJ, Torti FM, Tsiatis AA, Willan AR, Mark DB, et al. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. American Heart Journal. 149: 434-43. PMID 15864231 DOI: 10.1016/j.ahj.2004.11.001  0.44
2005 O'Brien BJ, Blackhouse G, Goeree R, Healey JS, Roberts RS, Gent M, Connolly SJ. Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 2: 270-5. PMID 15851317 DOI: 10.1016/j.hrthm.2004.12.021  0.44
2005 Pinto EM, Willan AR, O'Brien BJ. Cost-effectiveness analysis for multinational clinical trials. Statistics in Medicine. 24: 1965-82. PMID 15803442 DOI: 10.1002/sim.2078  0.44
2005 Zaric GS, O'brien BJ. Analysis of a pharmaceutical risk sharing agreement based on the purchaser's total budget. Health Economics. 14: 793-803. PMID 15685669 DOI: 10.1002/hec.976  0.44
2005 Willan AR, Pinto EM, O'Brien BJ, Kaul P, Goeree R, Lynd L, Armstrong PW. Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. Health Economics. 14: 327-38. PMID 15685652 DOI: 10.1002/hec.969  0.44
2004 Marshall DA, Levy AR, Vidaillet H, Fenwick E, Slee A, Blackhouse G, Greene HL, Wyse DG, Nichol G, O'Brien BJ. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Annals of Internal Medicine. 141: 653-61. PMID 15520421  0.44
2004 Lynd LD, O'brien BJ. Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis. Journal of Clinical Epidemiology. 57: 795-803. PMID 15485731 DOI: 10.1016/j.jclinepi.2003.12.012  0.44
2004 Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. Health Economics. 13: 405-15. PMID 15127421 DOI: 10.1002/hec.903  0.44
2003 Blackhouse G, Goeree R, O'Brien BJ. Methods for patient-level costing in the VA system: are they applicable to Canada? Medical Care Research and Review : McRr. 60: 142S-145S. PMID 15095550  0.44
2003 Sprague S, Cook DJ, Anderson D, O'Brien BJ. A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism. Thrombosis Research. 112: 193-201. PMID 14987911 DOI: 10.1016/j.thromres.2003.12.001  0.44
2003 Goeree R, O'Brien BJ. Cost-effectiveness modeling in rheumatology: toward principles of good practice. The Journal of Rheumatology. Supplement. 68: 21-2. PMID 14712617  0.44
2003 O'Brien BJ, Richardson RC, Berson DM. Inhibitory network properties shaping the light evoked responses of cat alpha retinal ganglion cells. Visual Neuroscience. 20: 351-61. PMID 14658764 DOI: 10.1017/S0952523803204016  1
2003 O'Brien BJ. Academy of Managed Care Pharmacy Format: relevance, rigor, regulation, and realism. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 6: 501-2. PMID 14627055 DOI: 10.1046/j.1524-4733.2003.65001.x  0.44
2003 O'Brien BJ, Spath M, Blackhouse G, Severens JL, Dorian P, Brazier J. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Economics. 12: 975-81. PMID 14601159 DOI: 10.1002/hec.789  0.44
2003 Marshall DA, O'Brien BJ, Nichol G. Review of economic evaluations of radiofrequency catheter ablation for cardiac arrhythmias. The Canadian Journal of Cardiology. 19: 1285-304. PMID 14571313  0.44
2003 Coyle D, Buxton MJ, O'Brien BJ. Measures of importance for economic analysis based on decision modeling. Journal of Clinical Epidemiology. 56: 989-97. PMID 14568631 DOI: 10.1016/S0895-4356(03)00176-8  0.44
2003 Giacomini M, Miller F, O'Brien BJ. Economic considerations for health insurance coverage of emerging genetic tests. Community Genetics. 6: 61-73. PMID 14560066 DOI: 10.1159/000072998  0.44
2003 Kamphuis W, Dijk F, O'Brien BJ. Gene expression of AMPA-type glutamate receptor subunits in rod-type ON bipolar cells of rat retina. The European Journal of Neuroscience. 18: 1085-92. PMID 12956708 DOI: 10.1046/j.1460-9568.2003.02841.x  1
2003 Lynd LD, O'Brien BJ. Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence. Journal of Cardiovascular Electrophysiology. 14: S99-103. PMID 12950529  0.44
2003 Habermann CJ, O'Brien BJ, Wässle H, Protti DA. AII amacrine cells express L-type calcium channels at their output synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6904-13. PMID 12890785  0.76
2003 Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique. 10: 67-71. PMID 12879144  0.44
2003 Levy AR, O'Brien BJ, McMullen E, May FW, Demers C, Marshall D, MacLeod S. Rapid increase in statins newly dispensed to Ontario seniors between 1994 and 2000. The Canadian Journal of Cardiology. 19: 665-9. PMID 12772016  0.44
2003 van Rossum MC, O'Brien BJ, Smith RG. Effects of noise on the spike timing precision of retinal ganglion cells. Journal of Neurophysiology. 89: 2406-19. PMID 12740401 DOI: 10.1152/jn.01106.2002  1
2003 Coyle D, Buxton MJ, O'Brien BJ. Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria. Health Economics. 12: 421-7. PMID 12720259 DOI: 10.1002/hec.788  0.44
2003 O'Brien BJ, Goeree R, Blackhouse G, Smieja M, Loeb M. Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 6: 116-25. PMID 12641862 DOI: 10.1046/j.1524-4733.2003.00213.x  0.44
2003 MacKeigan LD, Gafni A, O'Brien BJ. Double discounting of QALYs. Health Economics. 12: 165-9. PMID 12563665 DOI: 10.1002/hec.718  0.44
2003 Zupancic JA, Richardson DK, O'Brien BJ, Eichenwald EC, Weinstein MC. Cost-effectiveness analysis of predischarge monitoring for apnea of prematurity. Pediatrics. 111: 146-52. PMID 12509568 DOI: 10.1542/peds.111.1.146  0.44
2003 Habermann CJ, O'Brien BJ, Wässle H, Protti DA. All amacrine cells express L-type calcium channels at their output synapses Journal of Neuroscience. 23: 6904-6913.  1
2002 O'Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Statistical Methods in Medical Research. 11: 455-68. PMID 12516984 DOI: 10.1191/0962280202sm304ra  0.44
2002 O'Brien BJ. Economics and priority setting. Health Affairs (Project Hope). 21: 301. PMID 12224898  0.44
2002 Spath MA, O'Brien BJ. Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death. Pharmacoeconomics. 20: 727-38. PMID 12201792  0.44
2002 Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, Connolly SJ. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). American Heart Journal. 144: 282-9. PMID 12177646 DOI: 10.1067/mjh.2002.124049  0.44
2002 Marshall JK, Grootendorst PV, O'Brien BJ, Dolovich LR, Holbrook AM, Levy AR. Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 166: 1655-62. PMID 12126319  0.44
2002 Goeree R, O'Brien BJ, Blackhouse G, Marshall J, Briggs A, Lad R. Cost-effectiveness and cost-utility of long-term management strategies for heartburn. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 5: 312-28. PMID 12102694 DOI: 10.1046/j.1524-4733.2002.54145.x  0.44
2002 Coyle D, Lee KM, O'Brien BJ. The role of models within economic analysis: focus on type 2 diabetes mellitus. Pharmacoeconomics. 20: 11-9. PMID 12036380  0.44
2002 Blackhouse G, Briggs AH, O'Brien BJ. A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 22: 173-7. PMID 11958499 DOI: 10.1177/02729890222063053  0.44
2002 O'Brien BJ, Gertsen K, Willan AR, Faulkner LA. Is there a kink in consumers' threshold value for cost-effectiveness in health care? Health Economics. 11: 175-80. PMID 11921315 DOI: 10.1002/hec.655  0.44
2002 Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annual Review of Public Health. 23: 377-401. PMID 11910068 DOI: 10.1146/annurev.publhealth.23.100901.140534  0.44
2002 O'Brien BJ, Isayama T, Richardson R, Berson DM. Intrinsic physiological properties of cat retinal ganglion cells. The Journal of Physiology. 538: 787-802. PMID 11826165 DOI: 10.1113/jphysiol.2001.013009  1
2002 Marshall JK, Cawdron R, Yamamura DL, Ganguli S, Lad R, O'Brien BJ. Use and misuse of cost-effectiveness terminology in the gastroenterology literature: a systematic review. The American Journal of Gastroenterology. 97: 172-9. PMID 11811165 DOI: 10.1111/j.1572-0241.2002.05433.x  0.44
2002 O'Brien BJ, Abel PL, Olavarria JF. Connections of calbindin-D28k-defined subdivisions in inferior pulvinar with visual areas V2, V4 and MT in macaque monkeys Thalamus and Related Systems. 1: 317-330.  1
2001 O'Brien BJ, Goeree R, Bernard L, Rosner A, Williamson T. Cost-Effectiveness of tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: a Canadian perspective. Clinical Therapeutics. 23: 2038-49. PMID 11813937 DOI: 10.1016/S0149-2918(01)80156-9  0.44
2001 Willan AR, O'Brien BJ, Leyva RA. Cost-effectiveness analysis when the WTA is greater than the WTP. Statistics in Medicine. 20: 3251-9. PMID 11746316 DOI: 10.1002/sim.1018  0.44
2001 Tosteson AN, Jönsson B, Grima DT, O'Brien BJ, Black DM, Adachi JD. Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 12: 849-57. PMID 11716188 DOI: 10.1007/s001980170036  0.44
2001 Grootendorst PV, Dolovich LR, O'Brien BJ, Holbrook AM, Levy AR. Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 165: 1011-9. PMID 11699696  0.44
2001 O'Brien BJ, Abel PL, Olavarria JF. The retinal input to calbindin-D28k-defined subdivisions in macaque inferior pulvinar. Neuroscience Letters. 312: 145-8. PMID 11602331 DOI: 10.1016/S0304-3940(01)02220-0  1
2001 Agro K, Blackhouse G, Goeree R, Willan AR, Huang JQ, Hunt RH, O'Brien BJ. Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication. Pharmacoeconomics. 19: 831-43. PMID 11596835  0.44
2001 Sheldon R, O'Brien BJ, Blackhouse G, Goeree R, Mitchell B, Klein G, Roberts RS, Gent M, Connolly SJ. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study. Circulation. 104: 1622-6. PMID 11581139  0.44
2001 Levy AR, Briggs AH, Demers C, O'Brien BJ. Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada. American Heart Journal. 142: 537-43. PMID 11526370 DOI: 10.1067/mhj.2001.116479  0.44
2001 Iskedjian M, Einarson TR, O'Brien BJ, De Serres JG, Gold R, Gemmill IM, Milkovich N, Rosner A. Economic evaluation of a new acellular vaccine for pertussis in Canada. Pharmacoeconomics. 19: 551-63. PMID 11465300  0.44
2001 Willan AR, O'Brien BJ. Cost prediction models for the comparison of two groups. Health Economics. 10: 363-6. PMID 11400259 DOI: 10.1002/hec.615  0.44
2001 O'Brien BJ, Connolly SJ, Goeree R, Blackhouse G, Willan A, Yee R, Roberts RS, Gent M. Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). Circulation. 103: 1416-21. PMID 11245646  0.44
2000 Abel PL, O'Brien BJ, Olavarria JF. Organization of callosal linkages in visual area V2 of macaque monkey. The Journal of Comparative Neurology. 428: 278-93. PMID 11064367 DOI: 10.1002/1096-9861(20001211)428:2<278::AID-CNE7>3.0.CO;2-R  1
2000 O'Brien BJ. Chapter 3. Cost effectiveness of ICD therapy: a review of published evidence. The Canadian Journal of Cardiology. 16: 1307-12. PMID 11064306  0.44
2000 O'Brien BJ, Rosenfeld JV, Elder JE. Tension pneumo-orbitus and pneumocephalus induced by a nasal oxygen cannula: report on two paediatric cases. Journal of Paediatrics and Child Health. 36: 511-4. PMID 11036813 DOI: 10.1046/j.1440-1754.2000.00550.x  1
2000 O'Brien BJ, Yee R. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator. The Canadian Journal of Cardiology. 16: 45C-7C. PMID 10887279  0.44
2000 Marshall JK, Armstrong D, O'Brien BJ. Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 14: 379-88. PMID 10851277  0.44
2000 O'Brien BJ, Sculpher MJ. Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules. Medical Care. 38: 460-8. PMID 10800973  0.44
2000 Sculpher MJ, O'Brien BJ. Income effects of reduced health and health effects of reduced income: implications for health-state valuation. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 20: 207-15. PMID 10772358  0.44
2000 O'Brien BJ, Willan A, Blackhouse G, Goeree R, Cohen M, Goodman S. Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada? American Heart Journal. 139: 423-9. PMID 10689256  0.44
1999 Bala MV, Wood LL, Zarkin GA, Norton EC, Gafni A, O'Brien BJ. Are health states "timeless"? The case of the standard gamble method. Journal of Clinical Epidemiology. 52: 1047-53. PMID 10526998 DOI: 10.1016/S0895-4356(99)00074-8  0.44
1999 Goeree R, O'Brien BJ, Goering P, Blackhouse G, Agro K, Rhodes A, Watson J. The economic burden of schizophrenia in Canada. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 44: 464-72. PMID 10389607  0.44
1999 Goeree R, O'Brien BJ, Blackhouse G, Agro K, Goering P. The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 44: 455-63. PMID 10389606  0.44
1999 Willan AR, O'Brien BJ. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data. Health Economics. 8: 203-11. PMID 10348415 DOI: 10.1002/(SICI)1099-1050(199905)8:3<203::AID-HEC413>3.0.CO;2-7  0.44
1999 O'Brien BJ, Goeree R, Hux M, Iskedjian M, Blackhouse G, Gagnon M, Gauthier S. Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada. Journal of the American Geriatrics Society. 47: 570-8. PMID 10323651  0.44
1999 MacKeigan LD, O'Brien BJ, Oh PI. Holistic versus composite preferences for lifetime treatment sequences for type 2 diabetes. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 19: 113-21. PMID 10231073 DOI: 10.1177/0272989X9901900201  0.44
1998 Hux MJ, O'Brien BJ, Iskedjian M, Goeree R, Gagnon M, Gauthier S. Relation between severity of Alzheimer's disease and costs of caring. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 159: 457-65. PMID 9757169  0.44
1998 Johannesson M, O'Brien BJ. Economics, pharmaceuticals, and pharmacoeconomics. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 18: S1-3. PMID 9566460 DOI: 10.1177/0272989X98018002S01  0.44
1998 Chiba N, Bernard L, O'Brien BJ, Goeree R, Hunt RH. A Canadian physician survey of dyspepsia management. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 12: 83-90. PMID 9544418  0.44
1997 O'Brien BJ. A tale of two (or more) cities: geographic transferability of pharmacoeconomic data. The American Journal of Managed Care. 3: S33-9. PMID 10180339  0.44
1997 Anderson DR, O'Brien BJ. Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism. Pharmacoeconomics. 12: 17-29. PMID 10169385  0.44
1997 Zarnke KB, Levine MA, O'Brien BJ. Cost-benefit analyses in the health-care literature: don't judge a study by its label. Journal of Clinical Epidemiology. 50: 813-22. PMID 9253393 DOI: 10.1016/S0895-4356(97)00064-4  0.44
1997 O'Brien BJ, Abel PL, Olavarria JF. A morphological anomaly of the dorsal lateral geniculate nucleus in Macaca fascicularis. Cell and Tissue Research. 289: 11-6. PMID 9182596 DOI: 10.1007/s004410050847  1
1997 O'Brien BJ, Heyland D, Richardson WS, Levine M, Drummond MF. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. Jama. 277: 1802-6. PMID 9178794  0.44
1997 Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. Jama. 277: 1552-7. PMID 9153371  0.44
1997 Willan AR, O'Brien BJ, Cook DJ. Benefit-risk ratios in the assessment of the clinical evidence of a new therapy. Controlled Clinical Trials. 18: 121-30. PMID 9129856 DOI: 10.1016/S0197-2456(96)00092-X  0.44
1997 Grootendorst PV, O'Brien BJ, Anderson GM. On becoming 65 in Ontario. Effects of drug plan eligibility on use of prescription medicines. Medical Care. 35: 386-98. PMID 9107206  0.44
1997 Abel PL, O'Brien BJ, Lia B, Olavarria JF. Distribution of neurons projecting to the superior colliculus correlates with thick cytochrome oxidase stripes in macaque visual area V2. The Journal of Comparative Neurology. 377: 313-23. PMID 8989648 DOI: 10.1002/(SICI)1096-9861(19970120)377:3<313::AID-CNE1>3.0.CO;2-5  1
1996 Tasch RF, Goeree R, Henke CJ, O'Brien BJ. Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation. Pharmacoeconomics. 9: 61-75. PMID 10160088  0.44
1996 Sridhar S, Huang J, O'Brien BJ, Hunt RH. Clinical economics review: cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 10: 865-73. PMID 8971282  0.44
1996 Willan AR, O'Brien BJ. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. Health Economics. 5: 297-305. PMID 8880166 DOI: 10.1002/(SICI)1099-1050(199607)5:4<297::AID-HEC216>3.0.CO;2-T  0.44
1995 O'Brien BJ, Olavarria JF. Anomalous patterns of callosal connections develop in visual cortex of monocularly enucleated hamsters. Biological Research. 28: 211-8. PMID 9251751  1
1994 McIsaac W, Naylor CD, Anderson GM, O'Brien BJ. Reflections on a month in the life of the Ontario Drug Benefit Plan. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 150: 473-7. PMID 8313259  0.44
1994 O'Brien BJ, Anderson DR, Goeree R. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 150: 1083-90. PMID 8137188  0.44
1993 O'Brien BJ, Rusthoven J, Rocchi A, Latreille J, Fine S, Vandenberg T, Laberge F. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 149: 296-302. PMID 8339175  0.44
1993 Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J. Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty. Annals of Internal Medicine. 119: 1105-12. PMID 8239230  0.44
1992 Buxton MJ, O'Brien BJ. Economic evaluation of ondansetron: preliminary analysis using clinical trial data prior to price setting. The British Journal of Cancer. Supplement. 19: S64-7. PMID 1467204  0.44
1990 O'Brien BJ, Elswood J, Calin A. Perception of prescription drug risks: a survey of patients with ankylosing spondylitis. The Journal of Rheumatology. 17: 503-7. PMID 2348431  0.44
1990 O'Brien BJ, Elswood J, Calin A. Willingness to accept risk in the treatment of rheumatic disease. Journal of Epidemiology and Community Health. 44: 249-52. PMID 2273365  0.44
1990 O'Brien BJ, Buxton MJ, Khawaja HT. An economic evaluation of transdermal glyceryl trinitrate in the prevention of intravenous infusion failure. Journal of Clinical Epidemiology. 43: 757-63. PMID 2117054 DOI: 10.1016/0895-4356(90)90235-H  0.44
1989 Khawaja HT, O'Brien BJ, Buxton MJ, Weaver PC. Cost minimisation study of transdermal glyceryl trinitrate in reducing failures of peripheral intravenous infusion. Bmj (Clinical Research Ed.). 299: 97. PMID 2504347  0.44
1988 O'Brien BJ. A game-theoretic approach to donor kidney sharing. Social Science & Medicine (1982). 26: 1109-16. PMID 3293232 DOI: 10.1016/0277-9536(88)90186-4  0.44
1987 O'Brien BJ, Buxton MJ, Ferguson BA. Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis. Journal of Chronic Diseases. 40: 137S-158S. PMID 3298303  0.44
Show low-probability matches.